This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Texas patient defends US antitrust claims against US Anesthesia Partners

( April 7, 2025, 23:31 GMT | Official Statement) -- MLex Summary: US Anesthesia Partners’ motion to dismiss US monopolization claims over hospital anesthesia services in Texas should be denied, a plaintiff argued. “USAP argues that plaintiff’s claim depends solely on USAP’s ability to negotiate increased reimbursement rates from insurers—but plaintiff’s claim is not so limited. The complaint alleges that USAP’s monopolization increased prices in general, including the price from which the amount of Mr. Musharbash’s ultimate payment was derived,” the opposition said.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections